Recent BioUtah News & Events

Washington Post – The Senate is aiming to vote Wednesday on a $2 trillion stimulus package that is designed to flood the U.S. economy with money in an effort to stabilize households and businesses that have been floored by the coronavirus outbreak, according to an article published in the Washington Post. But Senate leaders were still working […]

Develop an overriding policy for how the company will respond to a COVID-19 outbreak and impacts. Helpful resources: Click here to download a copy of the World Health Organization’s guide to developing a “Strategic Preparedness and Response Plan for the New Coronavirus” CDC Business and Employer Guidance Implement a plan of action for counseling employees who […]

“March 24, 2020 – Today, the U.S. Food and Drug Administration took action to increase U.S. supplies to support the U.S. response to COVID-19 by providing instructions to manufacturersExternal Link Disclaimer importing personal protective equipment and other devices. One of FDA’s priorities in combating the COVID-19 pandemic is facilitating access to critical personal protective equipment (PPE) and […]

WASHINGTON—U.S. Senator Mitt Romney (R-UT) today announced the launch of a new webpage designed to keep Utahns informed during the coronavirus pandemic. The webpage, which serves as a reference guide for information from federal agencies, as well as state and local authorities, includes guidance for seniors and at-risk individuals, veterans, families and small businesses. The […]

“‘Today, the U.S. Food and Drug Administration took significant action to help increase the availability of ventilators and accessories, as well as other respiratory devices, during the COVID-19 pandemic to support patients with respiratory failure or difficulty breathing. ‘The FDA’s new actions will mean America can make more ventilators during this crisis,’ said Health and Human Services […]

Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals […]

FOR IMMEDIATE RELEASE: March 20, 2020 Media Contact: Ally Riding (202) 226-7721   Washington, DC— Today, Representative John Curtis (R-UT) sent a letter to United States Department of the Treasury Secretary Steven Mnuchin asking for relief for small businesses who are obligated to make paid leave payments to employees under the newly signed Families First […]

Courtesy of mcadams.house.gov Washington, D.C.—Legislation by Congressman Ben McAdams and Congressman Trey Hollingsworth (R-IN) giving commonsense regulatory relief for America’s growing companies was essentially adopted by the Securities and Exchange Commission (SEC) in a rule-making action. McAdams introduced the Fostering Innovation Act in 2019 as a narrow fix that allows small emerging growth companies to keep capital […]

TIME SENSITIVE – PLEASE TAKE SURVEY Dear Members of Utah’s Life Sciences Community, BioUtah is taking a multi-pronged approach to support our life sciences companies, industry workforce, and communities during the COVID-19 pandemic, including: Working directly with the Utah State Coronavirus Task Force to identify products and resources needed in the state Indentifing funding sources from […]

The Department of Health and Human Services issued a declaration on March 16 under the Public Readiness and Emergency Preparedness (“PREP”) Act to provide immunity to liability for activities related to medical countermeasures against COVID-19. The declaration is effective retroactively to February 4, 2020. The notice will be published in the Federal Register March 17. […]

Article courtesy of the National Association of Manufacturers Emergency Family and Medical Leave Expansion and Paid Sick Leave: • Creates a new “Public Health Emergency Leave” program under the Family and Medical Leave Act. Private employers, including manufacturers, under 500 employees are required to cover workers for a wide range of circumstances related to COVID-19 […]

Limit travel to only essential travel and have a clear definition of what constitutes “essential travel.” Monitor and share travel advisories and warning with employees. Click here for international travel news. Click here for CDC’s live Travel Health Alert Notice. Suspend travel to affected areas Develop a policy to address employees who refuse to work with co-workers […]

Identify possible work-related exposure and health risks to your employees. Train and educate employees about COVID-19. Here are some tools: Utah State Task Force Slide Deck Governor’s Recommendations Poster of Coronavirus symptoms for the work place Poster on “What you need to know and how to protect yourself from the Coronavirus” for the workplace Educational videos from the […]

The advent and progression of the Novel Coronavirus, COVID-19, pandemic requires a proper and measured response from every company and every employee. The impact of the spread of this virus is being reflected in the stock market, reductions in travel, supply chain management, sporting events, education and mass gatherings of every kind. While the effects […]

Today, President Trump sign a $8.3 billion emergency coronavirus funding measure, after it cleared both the House and Senate earlier in the week. View a summary of the legislation here. The bill would provide funding for diagnostics, treatments, and the purchase of medical supplies.

March 03, 2020 06:30 AM Eastern Standard Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests and that recently reported it had received a CE marking for its COVID-19 coronavirus assay, announced today that it has been requested to speak at […]

Nine rising startup companies from Utah’s growing life sciences industry will present their innovations to investors during the 2020 Entrepreneur & Investor Life Science Summit on February 28, sponsored by Simpson Thacher Salt Lake City, Utah – February 24, 2020 – BioUtah, Utah’s only trade association dedicated solely to the life sciences, in partnership with […]

Founder and CEO of Tolero Pharmaceuticals, David Bearss, Ph.D, and Managing Director and Head of Global Investment Opportunities Group of J.P. Morgan, Monica DiCenso, to address healthcare innovation and industry outlook at February 28 noted Utah life sciences event SALT LAKE CITY–(BUSINESS WIRE)–BioUtah, Utah’s only trade association dedicated solely to the life sciences, in partnership […]

ABC 4’s Good Morning Utah featured the 2020 Entrepreneur & Investor Summit this morning, sitting down with Keith Marmer, Executive Director of TVC at the University of Utah and the Salt Lake City Department of Economic Development’s Peter Makowski. The E&I Summit is Utah’s premier event for investment in the life sciences industry, bringing together up-and-coming companies, […]

Utah’s vibrant life sciences industry was on full display yesterday as part of the Governor’s Office of Economic Development’s “Industry Day on the Hill”. The event, held at the state capitol, provided legislators the opportunity to interact one-on-one with company exhibitors from the aerospace, life sciences and tech industries. Representing the life sciences sector were […]

In his State of the Union address February 5, President Trump highlighted a number of health policy goals, including lowering prescription drug prices. Drug pricing continues to be a priority for the Administration and a hot topic of debate for Republicans and Democrats alike. Trump specifically pledged to tackle high drug prices, increase transparency, work […]

An MOU was signed between the Hangzhou District, World Trade Center Utah and BioUtah indicating a desire to work together for the common good of all parties.

Game On: Groups Launch Competing Drug Pricing Ad Campaigns  With prospects dim, at least in the short-term, for passage of comprehensive drug pricing legislation in Congress, some Washington observers suggest President Trump is eager to push for regulatory changes in an effort to capture the high ground on lowering prescription drug costs ahead of the […]